These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32565368)

  • 1. The influence of hospital antimicrobial use on carbapenem-non-susceptible Enterobacterales incidence rates according to their mechanism of resistance: a time-series analysis.
    Ortiz-Brizuela E; Caro-Vega Y; Bobadilla-Del-Valle M; Leal-Vega F; Criollo-Mora E; López Luis BA; Esteban-Kenel V; Torres-Veintimilla E; Galindo-Fraga A; Olivas-Martínez A; Tovar-Calderón E; Torres-González P; Sifuentes-Osornio J; Ponce-de-León A
    J Hosp Infect; 2020 Aug; 105(4):757-765. PubMed ID: 32565368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia.
    Wu AY; Chang H; Wang NY; Sun FJ; Liu CP
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1229-1238. PubMed ID: 34824020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.
    Huang TD; Berhin C; Bogaerts P; Glupczynski Y;
    J Antimicrob Chemother; 2013 Aug; 68(8):1832-7. PubMed ID: 23557926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meropenem-Vaborbactam Activity against Carbapenem-Resistant
    Castanheira M; Doyle TB; Kantro V; Mendes RE; Shortridge D
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018.
    Kim SH; Kim GR; Jeong J; Kim S; Shin JH
    Jpn J Infect Dis; 2020 Nov; 73(6):431-436. PubMed ID: 32475870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization and epidemiology of carbapenem non-susceptible Enterobacteriaceae isolated from the Eastern region of Heilongjiang Province, China.
    Gong X; Zhang J; Su S; Fu Y; Bao M; Wang Y; Zhang X
    BMC Infect Dis; 2018 Aug; 18(1):417. PubMed ID: 30134844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with carriage of carbapenem-non-susceptible Enterobacteriaceaein North-Eastern France and outcomes of infected patients.
    Muggeo A; Guillard T; Barbe C; Thierry A; Bajolet O; Vernet-Garnier V; Limelette A; Brasme L; De Champs C;
    J Antimicrob Chemother; 2017 May; 72(5):1496-1501. PubMed ID: 28158526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mCIM test as a reliable assay for the detection of CRE in the Gulf region.
    Al Musawi S; Ur Rahman J; Aljaroodi SA; AlShammari L; Itbaileh A; Mohammed H; Saeed N; Abdalhamid B; Alkharsah KR; Aljindan RY
    J Med Microbiol; 2021 Jul; 70(7):. PubMed ID: 34232118
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of carbapenemase-producing Enterobacteriaceae from colonized patients in a university hospital in Madrid, Spain, during the R-GNOSIS project depicts increased clonal diversity over time with maintenance of high-risk clones.
    Hernández-García M; Pérez-Viso B; Carmen Turrientes M; Díaz-Agero C; López-Fresneña N; Bonten M; Malhotra-Kumar S; Ruiz-Garbajosa P; Cantón R
    J Antimicrob Chemother; 2018 Nov; 73(11):3039-3043. PubMed ID: 30053018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An agar plate-based modified carbapenem inactivation method (p-mCIM) for detection of carbapenemase-producing Enterobacteriaceae.
    Byun JH; Seo Y; Kim D; Kim M; Lee H; Yong D; Lee K; Chong Y
    J Microbiol Methods; 2020 Jan; 168():105781. PubMed ID: 31756348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance.
    van der Zwaluw K; Witteveen S; Wielders L; van Santen M; Landman F; de Haan A; Schouls LM; Bosch T;
    Clin Microbiol Infect; 2020 Oct; 26(10):1412.e7-1412.e12. PubMed ID: 32006688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Carbapenemase-Producing Enterobacteriaceae from Patients in Amman, Jordan.
    Aqel AA; Findlay J; Al-Maayteh M; Al-Kaabneh A; Hopkins KL; Alzoubi H; Masalha I; Turton J; Woodford N; Ellington MJ
    Microb Drug Resist; 2018 Oct; 24(8):1121-1127. PubMed ID: 29653473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
    Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Analysis of Mobile Genetic Elements Mediating β-Lactamase Gene Amplification in Noncarbapenemase-Producing Carbapenem-Resistant
    Shropshire WC; Konovalova A; McDaneld P; Gohel M; Strope B; Sahasrabhojane P; Tran CN; Greenberg D; Kim J; Zhan X; Aitken S; Bhatti M; Savidge TC; Treangen TJ; Hanson BM; Arias CA; Shelburne SA
    mSystems; 2022 Oct; 7(5):e0047622. PubMed ID: 36036505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbapenemase-producing Enterobacteriaceae isolates resistant to last-line antibiotics in an Italian general hospital.
    Ferranti M; Schiaroli E; Palmieri MI; Repetto A; Vecchiarelli A; Francisci D; Mencacci A; Monari C
    New Microbiol; 2018 Oct; 41(4):274-281. PubMed ID: 30252925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
    Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
    Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.
    Marimuthu K; Ng OT; Cherng BPZ; Fong RKC; Pada SK; De PP; Ooi ST; Smitasin N; Thoon KC; Krishnan PU; Ang MLT; Chan DSG; Kwa ALH; Deepak RN; Chan YK; Chan YFZ; Huan X; Zaw Linn K; Tee NWS; Tan TY; Koh TH; Lin RTP; Hsu LY; Sengupta S; Paterson DL; Perencevich E; Harbarth S; Teo J; Venkatachalam I;
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Occurrence of the OXA-198 Carbapenemase in
    Bonnin RA; Jousset AB; Gauthier L; Emeraud C; Girlich D; Sauvadet A; Cotellon G; Jové T; Dortet L; Naas T
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Bangkok, Thailand, and Their Detection by the Carba NP and Modified Carbapenem Inactivation Method Tests.
    Laolerd W; Akeda Y; Preeyanon L; Ratthawongjirakul P; Santanirand P
    Microb Drug Resist; 2018 Sep; 24(7):1006-1011. PubMed ID: 29782216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Within-a-Day Detection and Rapid Characterization of Carbapenemase by Use of a New Carbapenem Inactivation Method-Based Test, CIMplus.
    Caméléna F; Cointe A; Mathy V; Hobson C; Doit C; Bercot B; Decré D; Podglajen I; Dortet L; Monjault A; Bidet P; Bonacorsi S; Birgy A
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29950336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.